Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$162.75 USD

162.75
620,225

-1.18 (-0.72%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $162.74 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (49 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Derek Lewis headshot

3 Buy Rated Stocks Cruising at 52 Week Highs

Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are rolling in.

Tempus Stock Up Following Collaboration Expansion in Oncology R&D

TEM's latest expanded partnership is likely to leverage multimodal real-world datasets and biological model systems in oncology R&D.

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

DaVita HealthCare (DVA) closed the most recent trading day at $163.08, moving +0.51% from the previous trading session.

Should Value Investors Buy DaVita (DVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Here is how DaVita HealthCare (DVA) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.

Reasons to Retain Fresenius Medical Stock in Your Portfolio Now

FMS continues to gain traction on the back of its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.

Indrajit Bandyopadhyay headshot

DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?

DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.

Reasons to Retain Stryker Stock in Your Portfolio for Now

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

VEEV Stock Down Despite Expansion of Vault QMS to Boost Patient Safety

Veeva Systems' addition of new capabilities is likely to improve the timeliness and accuracy of field actions to ensure product quality and patient safety.

Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now

Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.

DaVita HealthCare (DVA) Stock Sinks As Market Gains: What You Should Know

DaVita HealthCare (DVA) concluded the recent trading session at $161.57, signifying a -0.01% move from its prior day's close.

Senseonics Stock Down Despite New FDA Approval for Eversense 365

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Centene's Michigan Unit Partners With Mae to Reduce Health Disparities

CNC's Meridian unit collaborates with Mae to improve health outcomes and address health disparities in Michigan.

MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout

Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio Now

ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.

Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market

DaVita HealthCare (DVA) closed the most recent trading day at $163.16, moving -0.65% from the previous trading session.

MASI Stock Gains as US Court Raises Concern About Politan's Ethics

Shares of Masimo have risen since the news of a court ruling against Politan. The ruling is likely to favor MASI's founder in the upcoming vote for new board members on Sept. 19.

Stryker Stock Declines Despite Completion of care.ai Acquisition

SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.

DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know

In the most recent trading session, DaVita HealthCare (DVA) closed at $164.22, indicating a -0.59% shift from the previous trading day.

Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OS

MASI's latest partnership is likely to develop a new reference platform that brings high-performing Wear OS smartwatches to market.

How to Find Strong Buy Medical Stocks Using the Zacks Rank

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

ARAY Stock Up Following the Use of SGRT on Cancer Patients in Japan

The latest adoption of Accuray's Radixact System and VitalHold package is likely to improve the care provided to cancer patients and their experience.

Zacks Investment Ideas feature highlights: Intuitive Surgical, SharkNinja and DaVita

Intuitive Surgical, SharkNinja and DaVita have been highlighted in this Investment Ideas article.